MIT Study Reveals APOE4 Gene Disruption of Neuron Insulation and Potential Interventions
- Published
- Source
- MITNews
A study from MIT's Picower Institute for Learning and Memory reveals how the APOE4 gene variant disrupts neuron insulation, a critical factor in Alzheimer's disease. The research indicates that APOE4 suppresses Wnt signaling in oligodendrocytes, leading to lipid droplet accumulation and impaired myelination. By restoring Wnt signaling, researchers demonstrated potential interventions that could reverse these effects in lab settings.
This discovery is significant as it enhances understanding of the molecular pathways involved in lipid metabolism defects associated with Alzheimer's. The findings suggest that targeting Wnt signaling could open new avenues for drug development aimed at mitigating the effects of the APOE4 gene variant. The study's innovative use of CRISPR gene editing provides a comprehensive approach to exploring genetic modifiers related to lipid accumulation in the central nervous system.
The research team plans to further investigate the molecular mechanisms underlying Wnt signaling suppression in APOE4 oligodendrocytes. They aim to explore additional therapeutic strategies that could restore myelination and improve neuronal function, particularly in the context of Alzheimer’s disease pathology.
Original report
How the biggest Alzheimer’s risk gene disrupts the process of insulating neurons
MITNews · David Orenstein | The Picower Institute for Learning and MemoryThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
Related Suppliers
Biomimetic Robotics Lab, MIT
United States
MIT Mechanical Engineering lab led by Prof. Sangbae Kim that created the Cheetah 3 and backflipping Mini Cheetah quadrupeds and the MIT Humanoid.
Mitsubishi Electric Automation, Inc.
United States
Vernon Hills, Illinois factory-automation subsidiary of Japan's Mitsubishi Electric; sells MELFA robots, MELSEC PLCs, and CNC systems in North America.
Mitsubishi Electric Corporation 三菱電機株式会社
Japan
Japanese multinational electronics and electrical equipment maker producing the MELFA series of industrial robots and comprehensive factory automation systems.
PARO Robots U.S., Inc.
United States
US distributor of PARO, the FDA-cleared therapeutic seal robot used in dementia and senior care settings.
University of Texas at Arlington — Next Gen Systems & Robotics (UTARI)
United States
Applied R&D institute of UT Arlington, Fort Worth TX, advancing robotics, automation, unmanned systems, biomedical tech, and autonomous vehicles for 30+ years.
Istituto Italiano di Tecnologia (IIT)
Italy
Italy's flagship public research foundation advancing robotics, AI, and neuroscience.
Neurobotics LLC
Russian Federation
Moscow-based neurotechnology company developing BCI devices, rehabilitation exoskeletons, and the ReviVR VR walk simulator for stroke patient recovery.
ViscoTec America Inc.
United States
ViscoTec America (Kennesaw, GA) is the US subsidiary of German dosing specialist ViscoTec (est. 1997), making precision dispensing systems for e-mobility.
Varda Space Industries
United States
Varda Space Industries is a US in-space manufacturing company that produces pharmaceuticals in microgravity orbit and returns them to Earth via reentry capsule.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
